Theriva Biologics stock price

시어리바 바이오로직스NYSEAMERICAN:TOVX · NYSE Amex · Healthcare · sector #17
$0.2220-1.33%
2026-10-06 close
Loading chart…

Today's signals · No active technical signal.

Signal details →

Theriva Biologics last closed at $0.2220 (-1.33%) on 2026-10-06. Listed on NYSE Amex. Trailing 12 months PER is -0.9×. Its overall grade ranks 580 of 740 stocks in Healthcare.

About this company

Theriva Biologics last closed at $0.2220 (-1.33%) on 2026-10-06. Listed on NYSE Amex.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall C · 580/740

Valuation grade C

Details →

Related stocks

  • AstraZenecaCompetitor

    항암·중증질환 치료제 개발 경쟁사

  • Merck & Co.Competitor

    종양학 신약 개발 및 면역항암제 경쟁사

  • 항암제 포트폴리오가 겹치는 대형 제약사

Details →
About Theriva Biologics
What technical signals does Theriva Biologics (TOVX) have?
Theriva Biologics current technical signals: no active technical signal.
Is Theriva Biologics a cup-and-handle pattern?
No. Theriva Biologics has no valid Cup signal right now.
What published figures are available for Theriva Biologics?
Market cap: $7.49M. Trailing 12 months PER: -0.9×. Latest quarter PBR: 0.84×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Turn what you saw on this name into a strategy

Ask Q about Theriva Biologics, or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Theriva Biologics notifications

Quantus Signal · live data · not investment advice · Privacy Policy